noom glp-1 companion program Noom: Lose weight and keep it off 🚨 INTRODUCING: Noom Proactive Health

He can no longer work because hes blind in both eyes

Since the mean/median duration for each of these studies was 100,000 patients prescribed a GLP-1RA, after propensity matching, there was reduced risk for PDAC during a 5-year observation period for GLP-1RA users compared to six categories of commonly used diabetes medication classes 44

adults currently use GLP-1 for weight loss Obesity rate: Declined from 39.9 percent (2022) to 36.4 percent (2026) based on self-reported BMI Diabetes diagnosis rate: Stable since 2023 after 15 years of gradual rise Important limitation: Self-reported data

Correspondence between cerebral glucose metabolism and BOLD reveals relative power and cost in human brain

That thing about a glass of red wine being good for your heart

GLP-1 analogues market size was exhibited at USD 18.61 billion in 2025 and is projected to be worth around USD 304.09 billion by 2035, growing at a CAGR of 32.23% from 2026 to 2036